|Over a week ago|
LiveRamp to replace Vera Bradley in S&P 600 at open on 6/21 04:5506/2106/21/22
ShockWave Medical to replace LiveRamp in S&P 400 at open on 6/21 04:5506/2106/21/22
LiveRamp joins Salesforce AppExchange » 08:2706/0806/08/22
LiveRamp (RAMP) announced…
LiveRamp (RAMP) announced it has joined the expanded Marketing Cloud Customer Data Platform ecosystem on Salesforce (CRM) AppExchange. "With the Customer Data Platform and LiveRamp's app coming soon to AppExchange, Salesforce customers will be able to enjoy enhanced reach and accuracy for all media activations. LiveRamp's RampID technology fully supports audience enrichment, targeting, measurement and optimization without sending PII to publishers, tech platforms, or data providers," the company said.
LiveRamp to replace Vera Bradley in S&P 600 at open on 6/21 17:4306/0306/03/22
ShockWave Medical to replace LiveRamp in S&P 400 at open on 6/21 17:4106/0306/03/22
|Over a month ago|
LiveRamp rolls out authenticated traffic solution to iQIYI » 21:0105/3105/31/22
LiveRamp "announced the rollout of its Authenticated Traffic Solution to iQIYI's streaming services, starting with services in Taiwan, Singapore, Japan and Australia. As a result of this integration, ATS will enable the world's top marketers to tap into the global streamer's addressable inventory for precision targeting, without relying on third-party identifiers such as third-party cookies, mobile ad IDs or IP addresses."
LiveRamp price target lowered to $30 from $60 at Craig-Hallum » 08:5705/2505/25/22
Craig-Hallum analyst Jason Kreyer lowered the firm's price target on LiveRamp to $30 from $60 and keeps a Buy rating on the shares. The analyst notes that while results were solid, bookings trends faded over the quarter leading to a shortfall to start fiscal 2023. Slower hiring efforts across 2022 started the company in a hole in terms of headcount, and instability is necessitating more caution in terms of outlook, Kreyer contends.
LiveRamp price target lowered to $50 from $90 at Susquehanna » 08:1505/2505/25/22
Susquehanna analyst Shyam…
Susquehanna analyst Shyam Patil lowered the firm's price target on LiveRamp to $50 from $90 and keeps a Positive rating on the shares. The analyst said the company posted a strong quarter with all of the key initiatives including ATS, Safe Haven, Advanced TV, all showing strong trends. Patil said he remains Positive on the company and believes they will continue to benefit from the trend toward attributable, data-driven advertising.
LiveRamp price target lowered to $58 from $67 at Stephens » 07:1105/2505/25/22
Stephens analyst Nicholas…
Stephens analyst Nicholas Zangler lowered the firm's price target on LiveRamp to $58 from $67 and keeps an Overweight rating on the shares. Though Q4 performance was "solid," the near-term outlook calling for 17% revenue growth in Q1 and 15%-18% for FY23 is likely to disappoint investors looking for a return to 25% revenue growth, Zangler contends. He is reducing his FY23 revenue and adjusted EBITDA estimates following the report, Zangler noted.
LiveRamp to buy back $150M of common stock by Q3-end under current program » 16:1105/2405/24/22
LiveRamp "also announced that it intends to repurchase approximately $150 million of its common stock by the end of the third quarter of fiscal 2023. Share repurchases will be made under the Company's existing share repurchase program that extends through December 31, 2022. Under its share repurchase program, LiveRamp is authorized to repurchase outstanding shares in the open market or privately negotiated transactions depending on prevailing market conditions, corporate and regulatory requirements, stock price, acquisition opportunities and other factors."